Dudediligence.

Compass Therapeutics, Inc

CMPXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25
Net income, by quarter
−$10.5MSep ’24−$15.0MDec ’24−$16.6MMar ’25−$19.9MJun ’25−$14.3MSep ’25−$15.7MDec ’25−$18.3MMar ’26−$25.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on file$0.00$850,000$0.00
Operating income−$81.9M−$41.7M−$50.4M−$56.6M−$72.8M
Net income−$82.2M−$39.2M−$42.5M−$49.4M−$66.5M
Operating cash flow−$19.7M−$34.1M−$40.6M−$44.9M−$49.1M
Free cash flow−$21.2M−$34.3M−$40.6M−$44.9M−$49.2M
Cash$144.5M$34.9M$24.2M$43.5M$30.6M
Debt$0.00none on filenone on filenone on filenone on file
Shares outstanding100.8M126.3M127.7M137.8M178.3M
CMPX fundamentals · DudeDiligence